Immunophotonics to Present at the 2024 ThinkEquity Conference
October 28, 2024
St. Louis, Missouri, October 28, 2024 – PRISM MediaWire – Immunophotonics, Inc. a clinical-stage biotech company focused on the discovery and development of novel immune-activating